The Walden Group was Engaged by Katalyst Surgical, LLC and Initiated Its Merger with Carl Zeiss Meditec AG

 The Walden Group is pleased to announce that it was engaged by Katalyst Surgical, LLC and initiated its merger with an affiliate of Carl Zeiss Meditec AG, one of the world’s leading medical technology companies traded on the German Stock Exchange.

Katalyst Surgical is a leader in vitreoretinal instruments, fiberoptic illumination, innovative light sources and other ophthalmic surgical technologies. Its novel technologies include: patented "Stiff Shaft' instruments that make small diameter instruments (27 ga) available via a retractable sleeve that stiffens and stabilize an instrument's shaft; groundbreaking technology that substantially widens the lighted surgical field and increases the light intensity inside the eye; Micro-Vacuum Pick (MVP) for grasping and peeling retinal membranes without the use of forceps; and "Multiflex" illuminated laser probes.

About The Walden Group

The Walden Group is a healthcare mergers & acquisition advisory firm. We represent privately-owned companies seeking to divest operations or find a home within an appropriate strategic or private equity firm. We also represent operating companies and financial sponsors seeking to make corporate acquisitions and investments in the healthcare sector. Our approach is "full-immersion", with more than 30 years of healthcare experience, deep industry knowledge, a worldwide network of close relationships and a lengthy track record of completed transactions.

www.waldenmed.com

The Walden Group, Inc.

560 White Plains Rd.

Tarrytown, NY 10591

914.332.9700

office@waldenmed.com